Koretz MM - Search Results

1

A comparison of the quality of participation of community affiliates and that of universities in the Northern California Oncology Group.

Koretz MM, Jackson PM, Torti FM, Carter SK. Koretz MM, et al. J Clin Oncol. 1983 Oct;1(10):640-4. doi: 10.1200/JCO.1983.1.10.640. J Clin Oncol. 1983. PMID: 6668485

2

Community vs. university physician performance and patient evaluability.

Jackson P, Koretz M, Hannigan J, Torti FM. Jackson P, et al. Prog Clin Biol Res. 1984;156:39-48. Prog Clin Biol Res. 1984. PMID: 6473447 Clinical Trial. No abstract available.

3

Pelvic irradiation plus adriamycin and cyclophosphamide in selected patients with epithelial ovarian carcinoma: a phase II study of the Northern California Oncology Group.

Ballon SC, Martinez A, Turbow MM, Koretz MM, Carter SK. Ballon SC, et al. Among authors: koretz mm. Gynecol Oncol. 1984 Nov;19(3):278-83. doi: 10.1016/0090-8258(84)90193-8. Gynecol Oncol. 1984. PMID: 6542049 No abstract available.

4

AMSA--a promising new agent in refractory acute leukemia.

Lawrence HJ, Ries CA, Reynolds RD, Lewis JP, Koretz MM, Torti FM. Lawrence HJ, et al. Among authors: koretz mm. Cancer Treat Rep. 1982 Jul;66(7):1475-8. Cancer Treat Rep. 1982. PMID: 7046928 Clinical Trial.

5

Adverse reactions to AMSA in medical personnel.

Reynolds RD, Ignoffo R, Lawrence J, Torti FM, Koretz M, Anson N, Meier A. Reynolds RD, et al. Cancer Treat Rep. 1982 Oct;66(10):1885. Cancer Treat Rep. 1982. PMID: 6215121 No abstract available.

6

A phase II study of prednimustine in acute non-lymphocytic leukemia, smouldering leukemia, and refractory anemia with excess blasts.

Gandara DR, Ries CA, Schiff SA, George CB, Lewis JP, Koretz MM, Carter SK. Gandara DR, et al. Among authors: koretz mm. Cancer Chemother Pharmacol. 1982;9(1):10-2. doi: 10.1007/BF00296753. Cancer Chemother Pharmacol. 1982. PMID: 7139848

7

Treatment of refractory chronic lymphocytic leukemia with prednimustine: a phase II study using strict response criteria.

Gandara DR, George CB, Ries CA, Koretz MM, Lewis JP. Gandara DR, et al. Among authors: koretz mm. Cancer Chemother Pharmacol. 1987;19(2):165-8. doi: 10.1007/BF00254572. Cancer Chemother Pharmacol. 1987. PMID: 3568275

8

Bleomycin, mitomycin, and cisplatin therapy for advanced squamous carcinoma of the uterine cervix: a phase II study of the Northern California Oncology Group.

Picozzi VJ Jr, Sikic BI, Carlson RW, Koretz M, Ballon SC. Picozzi VJ Jr, et al. Cancer Treat Rep. 1985 Jul-Aug;69(7-8):903-5. Cancer Treat Rep. 1985. PMID: 2410123

9

Cisplatin, doxorubicin, and cyclophosphamide chemotherapy for advanced endometrial carcinoma.

Turbow MM, Ballon SC, Sikic BI, Koretz MM. Turbow MM, et al. Among authors: koretz mm. Cancer Treat Rep. 1985 May;69(5):465-7. Cancer Treat Rep. 1985. PMID: 4039978

10

Evaluation of collagen/hydroxylapatite for augmenting deficient alveolar ridges: a preliminary report.

Mehlisch DR, Taylor TD, Leibold DG, Hiatt R, Waite DE, Waite PD, Laskin DM, Smith ST, Koretz MM. Mehlisch DR, et al. Among authors: koretz mm. J Oral Maxillofac Surg. 1987 May;45(5):408-13. doi: 10.1016/0278-2391(87)90008-5. J Oral Maxillofac Surg. 1987. PMID: 3033186

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page